Boldebold – Boldenone 200 mg/mL | Omega Lab
1. Product Overview
Boldebold 200 mg/mL is an injectable anabolic-androgenic steroid product marketed under the Omega Lab name. According to the supplied Roidsdeal and Finest Gears descriptions, each milliliter contains 200 mg of boldenone undecylenate, and each vial contains 10 mL of solution.
Boldenone undecylenate is a long-acting esterified form of boldenone, a synthetic anabolic-androgenic steroid structurally related to testosterone.
The compound is associated with androgen receptor activity and biological pathways involved in protein metabolism, tissue maintenance, and reproductive hormone regulation.
The supplied descriptions emphasize lean muscle development, strength, and physical performance. However, these claims should not be interpreted as established clinical benefits of this particular product.
The manufacturing standards, independent laboratory testing, sterility, and regulatory authorization of Omega Lab Boldebold 200 have not been verified.
2. What Is Boldebold 200?
Boldebold 200 is described as an injectable formulation containing boldenone undecylenate.
Boldenone is a synthetic anabolic-androgenic steroid derived from testosterone. The undecylenate ester modifies the compound’s release characteristics following administration.
Boldenone undecylenate has historically been associated with veterinary pharmaceutical use, particularly in horses.
It is not an FDA-approved medication for human use in the United States.
The compound belongs to the anabolic-androgenic steroid class rather than the selective androgen receptor modulator (SARM) class.
Its biological effects are not restricted to skeletal muscle and may involve the endocrine, cardiovascular, reproductive, and hematological systems.
The exact formulation of Omega Lab Boldebold 200, including its carrier oil, solvents, preservatives, and other inactive ingredients, has not been independently established.
3. How Does Boldenone Undecylenate Work?
Boldenone undecylenate acts as an esterified form of boldenone.
Following release from the formulation and cleavage of the ester, boldenone can interact with androgen receptors in various tissues.
Androgen receptors are intracellular proteins involved in regulating gene transcription and cellular responses to androgenic compounds.
Activation of these receptors influences biological pathways associated with protein metabolism, tissue maintenance, and reproductive hormone signaling.
The undecylenate ester is associated with relatively prolonged release compared with nonesterified boldenone.
However, the duration of action for a specific finished product depends on its formulation and other pharmacokinetic factors.
Boldenone may also influence erythropoiesis, the biological process responsible for red blood cell production.
An increase in red blood cell production is not necessarily beneficial. Excessive elevations in hematocrit may contribute to cardiovascular and thrombotic complications.
These pharmacological effects do not establish that Boldebold safely or predictably improves athletic performance.
4. Medical Uses & Clinical Information
Boldenone undecylenate has a history of veterinary use as an anabolic agent.
Veterinary formulations have been associated with selected clinical applications in horses, where anabolic effects were historically considered relevant.
However, veterinary authorization does not establish safety, effectiveness, or regulatory approval for human use.
Boldenone undecylenate is not FDA-approved for human medical treatment.
No verified human prescribing information, product-specific clinical trial evidence, or regulatory authorization has been supplied for Omega Lab Boldebold 200.
The supplied Roidsdeal and Finest Gears descriptions associate the product with muscle development, strength, muscle retention, and physical performance.
These are not established FDA-approved human therapeutic indications.
Boldenone is also prohibited in competitive sports under World Anti-Doping Agency regulations.
Its historical use in performance-enhancement settings should not be interpreted as evidence of safety or medical appropriateness.
5. Product Specifications & Packaging
| Specification | Details |
|---|---|
| Product Name | Boldebold 200 |
| Manufacturer | Omega Lab |
| Active Ingredient | Boldenone Undecylenate |
| Labeled Concentration | 200 mg/mL |
| Product Form | Injectable Solution |
| Package Size | 10 mL Vial |
| Administration Route | Injectable; Specific Route Unverified |
| Pharmacological Classification | Anabolic-Androgenic Steroid |
| Chemical Classification | Esterified Synthetic Testosterone Derivative |
| Release Characteristics | Long-Acting Ester |
| US Controlled Substance Status | Schedule III |
| FDA Approval for Human Use | Not Approved |
| Product-Specific Regulatory Authorization | Not Verified |
Both supplied sources agree on the active ingredient, manufacturer, concentration, and vial volume.
However, the exact inactive ingredients, sterility specifications, manufacturing standards, laboratory-testing results, and authenticity of the finished product remain unverified.
6. Administration & Medical Supervision
Boldebold 200 is described as an injectable product.
The labeled concentration of 200 mg/mL identifies the reported quantity of boldenone undecylenate per milliliter but does not establish an appropriate or safe human dose.
Because boldenone undecylenate is not approved for human use in the United States, there is no FDA-approved human dosing regimen for this product.
The supplied sources do not provide verified manufacturer instructions identifying the specific injection route.
Injectable products present additional safety concerns involving sterility, contamination, formulation compatibility, and injection-related complications.
Medical evaluation of suspected anabolic steroid exposure may involve blood pressure assessment, complete blood counts, hematocrit measurements, lipid testing, and endocrine evaluation.
The volume-to-milligram conversions included in the competitor description should not be interpreted as recommended dosing instructions.
Bodybuilding cycles, stacking protocols, and performance-enhancement regimens are not established medical treatment protocols.
7. Possible Side Effects
Boldenone undecylenate can produce adverse effects associated with anabolic-androgenic steroid exposure.
Potential adverse effects include:
- Acne and oily skin
- Increased facial or body hair
- Hair loss in genetically susceptible individuals
- Changes in libido
- Mood changes or irritability
- Suppression of natural testosterone production
- Menstrual irregularities
- Reduced sperm production and fertility disturbances
- Adverse changes in cholesterol concentrations
- Elevated hematocrit or red blood cell counts
The frequency and severity of these reactions depend on individual susceptibility and exposure.
More serious health concerns may include:
- Cardiovascular complications
- Hypertension
- Increased risk associated with excessive red blood cell production
- Reproductive and endocrine dysfunction
- Virilization in females
- Psychiatric or behavioral complications
- Liver-related abnormalities
- Injection-site infections or inflammatory reactions
Elevated hematocrit can increase blood viscosity and may contribute to cardiovascular complications.
Anabolic-androgenic steroid exposure can also adversely affect cholesterol concentrations and other cardiovascular risk factors.
Because Boldebold is marketed as an injectable formulation, contamination, infection, and tissue injury are additional concerns.
Symptoms such as chest pain, unexplained shortness of breath, severe headache, sudden neurological changes, or signs of a serious injection-site infection require immediate medical attention.
8. Warnings & Precautions
Boldenone is a Schedule III controlled anabolic steroid in the United States.
Boldenone undecylenate is not FDA-approved for human use.
Individuals with cardiovascular disease, hypertension, abnormal cholesterol levels, elevated hematocrit, or endocrine disorders may face additional complications.
Anabolic steroid exposure can suppress reproductive hormone production and impair fertility.
Exposure during pregnancy may harm fetal development and cause virilization.
Use in children and adolescents presents additional concerns because androgenic compounds can interfere with normal growth and sexual development.
Combining anabolic steroids with other substances that affect cardiovascular function or reproductive hormone regulation may increase health risks.
The absence of immediate symptoms does not establish that prolonged exposure is harmless.
9. Storage & Handling
Boldebold 200 is described as a 10 mL injectable product.
However, verified manufacturer storage temperatures, stability data, sterility documentation, and expiration specifications were not supplied.
Specific storage conditions should be confirmed using authentic manufacturer documentation.
Injectable products require particular attention to packaging integrity and contamination prevention.
A sealed vial does not independently establish sterility, correct ingredient identity, or suitability for human administration.
Keep pharmaceutical and veterinary substances in clearly identified packaging and away from children and pets.
Products with uncertain identity, compromised packaging, or unverified storage history should not be assumed safe for use.
10. Frequently Asked Questions (FAQs)
What is the active ingredient in Boldebold 200?
Boldebold 200 is described as containing boldenone undecylenate, an esterified anabolic-androgenic steroid derived from testosterone.
What is the labeled concentration?
Both supplied sources identify a concentration of 200 mg/mL.
What is the package size?
The product is described as being supplied in a 10 mL vial.
Why is boldenone undecylenate considered long-acting?
The undecylenate ester is associated with prolonged release characteristics compared with nonesterified boldenone.
11. Conclusion & Medical Disclaimer
Boldebold 200 is marketed as an injectable boldenone undecylenate product. Its human-use regulatory status, potential adverse effects, and unverified manufacturing quality require careful consideration.
This information is provided for educational and product-identification purposes only. It does not establish safety, effectiveness, or suitability for human administration and is not a substitute for professional medical advice.




Reviews
There are no reviews yet.